Chemical Structure (Sunosi Figure 1)
Sunosi Tablet, Film Coated
Product Images NDC 81968-350
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Sunosi (NDC 81968-350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Axsome Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Sunosi Figure 10
This is a professional sample of Suflosi ez (solriamfetol) tablets containing 7 tablets with each tablet containing 150mg. The NDC number is 81968-3 07 and this medication requires a prescription.*
Sunosi Figure 11
The text mentions Sunosi, a tablet medication that contains 150mg of something called sofarmfoto, which is equivalent to 01785mg of hyciochioride sl. The packaging recommends storing the tablets within a certain temperature range and keeping them away from children. However, the text appears to be incomplete and difficult to understand due to errors.*
Sunosi Figure 12
Figure 1 (Sunosi Figure 2)
This text provides information on the Fold Change and 90% confidence intervals for Renal PK Impairment Parameters including Mild, Moderate, and Severe cases represented by Cmax, AUCInf, and Change relative to reference. The values are given for various time intervals. AUCinf is defined as the area under the plasma concentration versus time curve from 0 hours extrapolated to infinity, while Cmax is defined as the maximum plasma concentration.*
Figure 2 (Sunosi Figure 3)
This appears to be tabulated data from a study on narcolepsy, comparing the effects of the medication Sunosi 75mg versus a placebo. The table shows the results of five test sessions conducted at different intervals (1, 3, 5, 7, and 9 hours post-dose) with corresponding standard error and least square mean values.*
Figure 3 (Sunosi Figure 4)
This appears to be a table showing the results of Study 2 for a drug called SUNOSI. Different doses (150mg, 75mg, and 375mg) are compared to a placebo over several test sessions at varying hours post-dose (1 hour, 3 hours, 5 hours, 7 hours, and 9 hours). The table includes standard error and least square mean data.*
81968-350-01 (75 mg 30 Count Bottle Label)
This is a description of a medication with the NDC code 81968-350-01. The medication is in the form of tablets with 75mg of soliamfetol (equivalent to 893mg hydrochloride salt). The tablets should be stored between 20°C and 25°C, with excursions to 15°C to 30°C permitted. This medication is a Schedule IV controlled substance and should be kept out of reach of children. It is distributed by Avsome Therapeutics, Inc. and comes with a Medication Guide.*
81968-350-01 (150 mg 30 Count Bottle Label)
This is a medication called Solriamfetol with a dosage of 150mg per tablet. The tablets contain hydrochloride and should be stored in a temperature range of 20°C to 25°C (68°F to 77°F). The medication guide should be consulted for dosage and usage instructions. The medication should be kept out of reach of children. Distributed by Axsome Therapeutics, Inc. and available as 30 tablets under Rx only label.*
81968-350-10 (75mg Physician Sample Label)
81968-351-10 (150 mg Physician Sample Label)
Sunosi Figure 9
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
